GoodRx , the leading prescription savings platform in the U.S., today announced it is offering free online healthcare provider visits to California residents impacted by the wildfires devastating Los ...

Stay updated on the latest potential FDA drug approvals in 2025, including an expanded label for Ozempic and new, nonopioid painkillers.

Analysts have set 12-month price targets for GoodRx Holdings, revealing an average target of $6.25, a high estimate of $7.00, ...

GoodRx returned to sequential growth in subscribers in Q3, showing potential for profit improvement. Read why I upgrade GDRX ...

GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced a new GoodRx for Pets ...

Discover the top 19 most notable drugs approved by the FDA in 2024, including Dupixent for COPD and FluMist for self-administration. See the full list here.

GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of ...

Santa Monica-based prescription drug savings platform GoodRx Holdings Inc. has hired a pharmacy benefits industry veteran as ...

The lawsuit focuses on a specific setup involving GoodRx, a telemedicine company that lets you track prescription costs and provides discounts on drugs. The company, in partnership with Pharmacy ...

Christmas is coming and with it the complications of finding places still open or working during the festive period. Many places will be shutting up shop for a few days and so getting ahead of the ...

GoodRx Inc. orchestrated a pricing scheme that benefited it and other big pharmacy benefit managers at the expense of independent pharmacies, a proposed class action filed in federal court says. The ...

GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that executives from the Company will participate in a fireside ...